--Indian pharmaceutical group Dr. Reddy's Laboratories is in ongoing talks to buy the anti-smoking aid Nicotinell from Haleon, Sky News reports, citing unnamed sources.

--Financial details regarding how much Dr Reddy's might pay to Haleon--which was spun out of GSK and Pfizer's consumer-healthcare business--remain unclear, but it is unlikely to be as much as the $800 million suggested in a previous report, Sky News reports.

--The companies weren't immediately available for comment.


Full story: https://bit.ly/3HFrAOx


Write to Michael Susin at michael.susin@wsj.com


(END) Dow Jones Newswires

01-16-24 0843ET